The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2025
Filed:
May. 18, 2023
Applicant:
B3ar Therapeutics, Inc., Palo Alto, CA (US);
Inventors:
Raymond E. Stevens, West Chester, PA (US);
Dalian Zhao, Fanwood, NJ (US);
Bingidimi Itute Mobele, Altamont, NY (US);
Assignee:
B3AR THERAPEUTICS, INC., Palo Alto, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 229/52 (2006.01); A61K 31/196 (2006.01); A61K 45/06 (2006.01); C07C 227/16 (2006.01); C07D 233/26 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07C 229/52 (2013.01); A61K 31/196 (2013.01); A61K 45/06 (2013.01); C07C 227/16 (2013.01); C07D 233/26 (2013.01); C07D 498/04 (2013.01); C07B 2200/13 (2013.01);
Abstract
This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.